Advertisement

The Diagnosis and Classification of Malignant Lymphomas

  • D. H. Wright
Part of the Immunology and Medicine Series book series (IMME, volume 15)

Abstract

Before embarking on the controversies and complexities of the classification of lymphomas, it is worth stressing the need for accurate diagnosis and the means of achieving this. In terms of clinical management, the distinction between reactive processes and malignant lymphomas and between lymphomas and carcinomas is of greater importance than the detailed sub-classification of lymphomas. The histopathology of resected lymph nodes and other tissues remains the mainstay of lymphoma diagnosis, and the need for good fixation and high quality sections is paramount. The majority of pathologists rely on their standard haematoxylin and eosin (H&E) stain, but increasingly in Europe Giemsa is the stain of choice for the diagnosis of lymphoreticular disease. This technique certainly provides contrasts, and highlights features such as cytoplasmic basophilia that are not always apparent in H&E stained sections and it is worth using as an additional, if not as the primary, stain. In our laboratory the ‘lymph node set’ comprises H&E, Giemsa (methyl green pyronin may be substituted), reticulin (identifies basic architecture and reveals characteristic patterns of some lymphomas), periodic acid Schiff (reveals basement membranes, mucus in epithelial cells, IgM in some lymphomas).

Keywords

Malignant Lymphoma Mycosis Fungoides Composite Lymphoma Kiel Classification Follicle Centre Cell 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Rowley, J. D. (1982). Identification of the constant chromosome regions involved in human hematologic malignant disease. Science,216, 749–51PubMedCrossRefGoogle Scholar
  2. 2.
    Yunis, J. J., Oken, M. M., Kaplan, M. E., Ensrud, K. M., Howe, R. R. and Theoligides, A. (1982). Distinctive chromosomal abnormalities in histologic subtypes of non-Hodgkin’s lymphoma. N. Engl. J. Med., 307 1231–6PubMedCrossRefGoogle Scholar
  3. 3.
    Levine, E. G., Arthur, D. C., Frizzera, G., Peterson, B. A., Hurd, D. D. and Bloomfield, C. D. (1985). There are differences in cytogenetic abnormalities among histologic subtypes of the non-Hodgkin’s lymphomas. Blood,66, 1414–22PubMedGoogle Scholar
  4. 4.
    Yunis, J. J., Frizzera, G., Oken, M. M., McKenna, J., Theologides, A. and Arnesen, M. (1987). Multiple recurrent genomic defects in follicular lymphoma. A possible model for cancer. N. Engl. J. Med., 316 79–84PubMedCrossRefGoogle Scholar
  5. 5.
    Manalova, Y., Manolov, G., Kieler, J., Levan, A. and Klein, G. (1979). Genesis of the 14q+ in Burkitt’s lymphoma. Hereditas, 90 5–10CrossRefGoogle Scholar
  6. 6.
    Lenoir, G. M., Preud, Homme, J. L., Bernheim, A. and Berger, R. (1982). Correlation between immunoglobulin light chain expression and variant translocation in Burkitt’s lymphoma. Nature, 298 474–6.Google Scholar
  7. 7.
    Weis, L. M., Warnke, R. A., Sklar, J. and Cleary, M. L. (1987). Molecular analysis of the t(14;18) chromosomal translocation in malignant lymphomas. N. Engl. J. Med.,317 1185–9CrossRefGoogle Scholar
  8. 8.
    Arnold, A., Cossmann, J., Bakshi, A., Jaffe, E., Waldmann, T. A. and Korsmeyer, S. J. (1983) Immunoglobulin gene rearrangements as unique clonal markers in human lymphoid neoplasms. N. Engl. J. Med.,309 1593–9PubMedCrossRefGoogle Scholar
  9. 9.
    O’Connor, N. T. J., Wainscoat, J. S., Weatherall, D. J. et al. (1985). Rearrangement of the T-cell receptor beta-chain gene in the diagnosis of lymphoproliferative disorders. Lancet, 1, 1295–7PubMedCrossRefGoogle Scholar
  10. 10.
    Waldmann, T. A., Davis, M. M., Bongiovanni, K. F. and Korsmeyer, S. J. (1985). Rearrangement of genes for the antigen receptor on T-cells as markers of lineage and clonality in human lymphoid neoplasms. N. Engl. J. Med., 313 776–83PubMedCrossRefGoogle Scholar
  11. 11.
    Williams, M. E., Innes, D. J., Borowitz, M. J., Lovell, M. A., Swerdlow, S. H., Hurtubise, P. E., Brynes, R. K., Chan, W. C., Byrne, G. E., Whitcombe, C. C. and Thomas, C. Y. (1987). Immunoglobulin and T-cell receptor gene rearrangements in human lymphoma and leukemia. Blood, 69 79–86PubMedGoogle Scholar
  12. 12.
    Ramsay, A. D., Smith, W. J. and Isaacson, P. G. (1988). T-cell-rich B-cell lymphoma. Am. J. Surg. Pathol., 12 433–43PubMedCrossRefGoogle Scholar
  13. 13.
    Gerard-Marchant, R., Hamlin, I., Lennert, K., Rilke, F., Stansfeld, A. G. and van Unnik, J. A. M. (1974). Classification of non-Hodgkin’s lymphomas. Lancet,2 406–8Google Scholar
  14. 14.
    Rappaport, H. (1966). Tumors of the Hematopoietic System. Atlas of Tumor Pathology, Section 3, Fasc 8. (Washington DC: Armed Forces Institute of Pathology)Google Scholar
  15. 15.
    Lukes, R. J. and Collins, R. D. (1977). Lukes-Collins classification and its significance. Cancer 71heat. Rep., 61 971--9Google Scholar
  16. 16.
    Bennett, M. H., Farrer-Brown, G., Henry, K. and Jelliffe, A. M. (1974). Classification of non-Hodgkin’s lymphomas. Lancet,2, 405–6CrossRefGoogle Scholar
  17. 17.
    Dorfman, R. F. (1974). Classification of non-Hodgkin’s lymphoma. Lancet,1 1295PubMedCrossRefGoogle Scholar
  18. 18.
    Mathé, G. Rappaport, H., O’Conor, G. T. et al. (1976). Histological and cytological typing of neoplastic diseases of haematopoietic and lymphoid tissues. In WHO International Histological Classification of Tumours, No 14. (Geneva: World Health Organisation)Google Scholar
  19. 19.
    Rosenberg, S. A., Bernard, C. W., Brown, B. W. et al. (1982). National Cancer Institute sponsored study of classification of non-Hodgkin’s lymphomas. Summary and description of a working formulation for clinical usage. The non-Hodgkin’s lymphoma pathologic classification project. Cancer, 49 2112–35CrossRefGoogle Scholar
  20. 20.
    Norton, A. J. and Isaacson, P. G. (1987). Detailed phenotype analysis of B-cell lymphoma, using a panel of antibodies reactive in routinely fixed, wax-embedded tissue. Am. J. Pathol.,128 225–40PubMedGoogle Scholar
  21. 21.
    Ng, C. S., Chan, J. K. C., Hui, P. K. and Lo, S. T. H. (1988). Monoclonal antibodies reactive with normal and neoplastic T-cells in paraffin sections. Hum. PathoL, 19 295–303PubMedCrossRefGoogle Scholar
  22. 22.
    Picker, L. J., Brenner, M. B., Weiss, L. M., Smith, S. D., Warnke, R. A. (1987). Discordant expression of CD3 and T-cell receptor beta-chain antigens in T-lineage lymphomas. Am. J. PathoL, 129 434–40PubMedGoogle Scholar
  23. 23.
    Smith, J. L., Haegert, D. G., Hodges, E., Stacey, G. N., Howell, W. M., Wright, D. H., Jones, D. B. Phenotypic and genotypic heterogeneity of peripheral T-cell lymphoma. Br. J. Cancer. (In press)Google Scholar
  24. 24.
    Lennert, K. (1981). Histopathology of Non-Hodgkin’s Lymphomas (based on the Kiel Classification). (Berlin: Springer-Verlag)Google Scholar
  25. 25.
    Weisenburger, D. D., Nathwani, B. N., Diamond, L. W., Winberg, C. D. and Rappaport, H. (1981). Malignant lymphoma intermediate lymphocytic type: A clinicopathologic study of 42 cases. Cancer,48 1415–25PubMedCrossRefGoogle Scholar
  26. 26.
    Weisenburger, D. D., Kim, H. and Rappaport, H. (1982). Mantle zone lymphoma: A follicular variant of intermediate lymphocytic lymphoma. Cancer, 49 1429–38PubMedCrossRefGoogle Scholar
  27. 27.
    Swerdlow, S. H., Habeshaw, J. A., Murray, L. J., Dhaliwal, H. S., Lister, T. A. and Stansfeld, A. G. (1983). Centrocytic lymphoma: A distinct clinicopathologic and immunologic entity. A multiparameter study of 18 cases at diagnosis and relapse. Am. J. Pathol., 113 181–7PubMedGoogle Scholar
  28. 28.
    Isaacson, P. and Wright, D. H. (1984). Extranodal malignant lymphoma arising from mucosa-associated lymphoid tissue. Cancer,53 2515–24PubMedCrossRefGoogle Scholar
  29. 29.
    Isaacson, P. G. and Spencer, J. (1987). Malignant lymphoma of mucosa-associated lymphoid tissue. Histopathology, 11 445–62PubMedCrossRefGoogle Scholar
  30. 30.
    Hodgkin, T. (1832). On some morbid appearances of the absorbent glands and spleen. Med. Chir. Trans., 17 68–114PubMedGoogle Scholar
  31. 31.
    Fox, H. (1926). Remarks on the presentation of microscopical preparations made from some of the original tissue described by Thomas Hodgkin, 1832. Ann. Med. Hist., 8 370–4Google Scholar
  32. 32.
    Lukes, R. J., Butler, J. J. and Hicks, E. B. (1966). Natural history of Hodgkin’s disease as related to its pathologic picture. Cancer,19 317–44CrossRefGoogle Scholar
  33. 33.
    Lukes, R. J., Craver, L. F., Hall, T. C., Rappaport, H. and Rubin, P. (1966). Report of the nomenclature committee. Cancer Res., 26 1311Google Scholar
  34. 34.
    Jackson, H. Jr. and Parker, F. Jr. (1947). Hodgkin’s Disease and Allied Disorders. (New York: Oxford University Press)Google Scholar
  35. 35.
    Haybittle, J. L., Hayhoe, F. G. J., Easterling, M. J., Jelliff, A. M., Bennett, M. H., Vaughan Hudson, G., Vaughan Hudson, B. and MacLennan, K. A. (1985). Review of British National Lymphoma Investigation studies of Hodgkin’s disease and development of prognostic index. Lancet, 1 967–72PubMedCrossRefGoogle Scholar
  36. 36.
    Pinkus, G. S. and Said, J. W. (1985). Hodgkin’s disease, lymphocyte predominance type, nodular - A distinct entity. Am. J. Pathol., 118 1–6PubMedGoogle Scholar
  37. 37.
    Greer, J. P., Kinney, M. C., Cousar, J. B., Flexner, J. M., Dupont, W. D., Graber, S. E., Greco, F. A., Collins, R. D. and Stein, R. S. (1986). Lymphocyte depleted Hodgkin’s disease. Clinicopathologic review of 25 patients. Am. J. Med., 81 208–14PubMedCrossRefGoogle Scholar
  38. 38.
    Kant, J. A., Hubbard, S. M., Longo, D. L., Simon, R. M., DeVita, V. T., Jaffe, E. S. (1986). The pathologic and clinical heterogeneity of lymphocyte depleted Hodgkin’s disease. J. Clin. Oncol., 4 284–94PubMedGoogle Scholar
  39. 39.
    Hui, P. K., Feller, A. C. and Lennert, K. (1988). High-grade non-Hodgkin’s lymphoma of B-cell type. I. Histopathology. Histopathology, 12 127–43PubMedCrossRefGoogle Scholar
  40. 40.
    Weinberg, D. S. and Pinkus, G. (1981). Non-Hodgkin’s lymphoma of large multilobated cell type. A clinicopathologic study of ten cases. Am. J. Clin. Pathol., 76, 190–6PubMedGoogle Scholar
  41. 41.
    Bennett, J. M., Catovsky, D., Daniel, M. T., Flandrin, G., Galton, D. A. G., Gralnick, H. R. and Sultan, C. (1976). Proposals for the classification of the acute leukaemias. Br. J. Haematol., 33, 451–8PubMedCrossRefGoogle Scholar
  42. 42.
    Stansfeld, A. G., Diebold, J., Noel, H. et al. (1988). Updated Kiel classification for lymphomas. Lancet, 1, 292–3PubMedCrossRefGoogle Scholar
  43. 43.
    Levine, P. H., Kamaraju, L. S., Connelly, R. R., Berard, C. W., Dorfman, R. F., Magrath, I. and Easton, J. M. The American Burkitt’s lymphoma Registry. Eight years experience. Cancer, 49, 1016–22Google Scholar
  44. 44.
    Mann, R. B., Jaffe, E. S., Braylan, R. C., Nanba, K., Frank, M. M., Ziegler, J. L. and Berard, C. W. (1976). Non-endemic Burkitt’s lymphoma, a B-cell tumor related to germinal centers. N. Engl. J. Med., 295, 685–91PubMedCrossRefGoogle Scholar
  45. 45.
    Wright, D. H. (1985). Histogenesis of Burkitt’s lymphoma: A B-cell tumour of mucosa-associated lymphoid tissue. In Lenoir, G., O’Conor, G. and Olweny, C. L. M. (eds); Burkitt’s Lymphoma: A Human Cancer Model, IARC Scientific Publications No 60. (Lyon: International Agency for Research on Cancer)Google Scholar
  46. 46.
    Uchiyama, T., Yodoi, J., Sagawa, K., Tatsuki, K. and Uchino, H. (1977). Adult T-cell leukemia: Clinical and hematologic features of 17 cases. Blood, 50, 481–92PubMedGoogle Scholar
  47. 47.
    Catovsky, D., Greaves, M. F., Rose, M. et al. (1982). Adult T-cell lymphoma-leukaemia in blacks from the West Indies. Lancet, 1, 639–43PubMedCrossRefGoogle Scholar
  48. 48.
    Weiss, L. M., Trela, M. J., Cleary, M. L., Turner, R. R., Warnke, R. A. and Sklar, J. (1985). Frequent immunoglobulin and T-cell receptor gene rearrangements in `histiocytic’ neoplasms. Am. J. Pathol., 121, 369–73PubMedGoogle Scholar
  49. 49.
    Isaacson, P. G., O’Connor, N. T. J., Spencer, J., Bevan, D. H., Connolly, C. E., Kirkham, N., Pollock, D. J., Wainscoat, J. S., Stein, H. and Mason, D. Y. (1986). Malignant histiocytosis of the intestine: A T-cell lymphoma. Lancet, 2, 688–91Google Scholar
  50. 50.
    Isaacson, P. and Wright, D. H. (1983). Malignant lymphoma of mucosa-associated lymphoid tissue. A distinctive type of B-cell lymphoma. Cancer, 52, 1410–16PubMedCrossRefGoogle Scholar
  51. 51.
    Cornes, J. S. (1961). Multiple lymphomatosis polyposis of the gastrointestinal tract. Cancer, 14, 249–57PubMedCrossRefGoogle Scholar
  52. 52.
    Isaacson, P. G., MacLennan, K. A. and Subbuswamy, S. G. (1984). Multiple lymphomatous polyposis of the gastrointestinal tract. Histopathology, 8,641–56.PubMedCrossRefGoogle Scholar

Copyright information

© Kluwer Academic Publishers 1990

Authors and Affiliations

  • D. H. Wright

There are no affiliations available

Personalised recommendations